Streltima 130 mg, Konzentrat zur Herstellung einer Infusionslösung

7680705230013 CH-70523 Konzentrat

Associated product:

STRELTIMA conc perf 130mg/26ml mg flac

No image available

Article details

Package size
1
Selling units
1
Measure
Durchstechflasche(n)
Galenic form
Konzentrat
Galenic group
Tinkturen/Desinfektion

Official Swissmedic V2 data

Additional information from the official database

Detailed composition

Substance Quantity Type Category
ustekinumabum
130.0 MG Substance Wirkstoff (Principe actif)
histidinum
- Substance HIMDK
histidini hydrochloridum monohydricum
- Substance HNIDK
saccharum
- Substance HNIDK
polysorbatum 80
- Substance HNIDK
dinatrii edetas
- Substance HNIDK
methioninum
- Substance HIMDK
aqua ad iniectabile
- Substance HNIDK
natrium
2.5 UGML Substance HBESI

Authorization holder

Janssen-Cilag AG

6300 Zug

Authorization information

Swissmedic authorization number
70523
Drug name
Streltima, Konzentrat zur Herstellung einer Infusionslösung
Galenic form
LSPA
ATC Code
L04AC05
Authorization status
Z
Authorization category
Category C
Dispensing category
B
First authorization
30/09/2025
Authorization expiration date
30/09/2026
IT Number
07.15.0.
Domain
Human medicine
Field of application
Morbus Crohn, Ulcerative Colitis

Package details

Description (FR)
STRELTIMA conc perf 130mg/26ml mg flac
Description (DE)
STRELTIMA Inf Konz 130mg/26ml mg Durchstf
Market launch
24/12/2026
Narcotic (BTM)
No
Buy us a coffee Explore the data